Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ORGAN FIBROSIS COMPRISING MONOMETHYL FUMARATE AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2022/114459
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating organ fibrosis comprising monomethyl fumarate as an active ingredient, the pharmaceutical composition comprising monomethyl fumarate as an active ingredient effectively inhibiting expression of collagen I and extracellular matrix components in cells known to have elevated accumulation thereof in organ fibrosis patients to thus be effective in preventing or treating organ fibrosis.
More Like This:
Inventors:
OH CHANG JOO (KR)
KIM MYUNG-HWA (KR)
PYO JUNG-IN (KR)
KIM MYUNG-HWA (KR)
PYO JUNG-IN (KR)
Application Number:
PCT/KR2021/011365
Publication Date:
June 02, 2022
Filing Date:
August 25, 2021
Export Citation:
Assignee:
CURACLE CO LTD (KR)
International Classes:
A61K31/22; A23L33/10; A61P43/00
Domestic Patent References:
WO2018095056A1 | 2018-05-31 |
Foreign References:
KR101379427B1 | 2014-03-28 | |||
JP2018131429A | 2018-08-23 | |||
US20140057917A1 | 2014-02-27 |
Other References:
PASCALE CRISSEY L, MARTINEZ ALEJANDRA N, CARR CHRISTOPHER, SAWYER DAVID M, RIBEIRO-ALVES MARCELO, CHEN MIMI, O'DONNELL DEVON B, GU: "Treatment with dimethyl fumarate reduces the formation and rupture of intracranial aneurysms: Role of Nrf2 activation", JOURNAL OF CEREBRAL BLOOD FLOW & METABOLISM, vol. 40, no. 5, 1 May 2020 (2020-05-01), US , pages 1077 - 1089, XP055932346, ISSN: 0271-678X, DOI: 10.1177/0271678X19858888
Attorney, Agent or Firm:
LEE, Won Hee (KR)
Download PDF: